Recombinant Proteins:

BioStart package: From Gene to Manufacturing

Tailored CMC solutions for biotech companies 

Our custom-designed BioStart package is built to support you at every step in your early-phase drug development.

Designed by our recombinant protein team, BioStart is tailored to the unique needs of biotech companies requiring CMC development and recombinant protein production in mammalian systems.

BioStart

What you get with BioStart

BioStart for biotechs
Biostart what you get

  • Our biotech services in every stage:

Transient
Gene
Expression

Cell
Line
Development

Purification and
Downstream
Process Development

Characterization
and
Analysis

Formulation

Manufacturing

  • Please click on the desired topic in the value chain below to explore further:

Transient Gene Expression

Cell Line Development

Purification and Downstream Process Development

Characterization and Analysis

Formulation

Manufacturing

Why we created BioStart

Our team of recombinant protein experts kept noticing the challenges biotech companies face — bottlenecks in early development, uncertainties in scaling up, the need for a seamless path from gene to manufacturing, financial concerns, and the need for R&D sparring.

We realized that with our expertise, network, and resources, we could help.

That´s why we have designed our BioStart package to provide:

  • Quick start times – Get your project moving faster
  • Early CMC insights to de-risk your process – Avoid costly setbacks
  • CMC hand-in-hand with in vitro modelling – Leave your molecule in the hands of experts
  • A robust, transferable process designed for upscaling – Simplify tech transfer

It’s our way of making sure biotech companies have the right support to move forward with confidence.

Biostart package for biotechs

How we´ve helped biotech companies 

Case

Full Development of Complex Protein

A small biotech company faced significant challenges expressing and purifying a complex protein, which was only producible as inclusion bodies (IBs) in E. coli. With limited data on the protein’s mechanism or mode of action, they required a partner to drive development.

Case

Modular Biotech Package for Investor Interest

A very early-stage biotech company with limited funding needed to build a solid data package to attract investor interest. While initial protein expression had been done, a properly cell line and scalable process were essential for moving forward.

Case

Flexible Research & Development Services

An established virtual biotech with a growing pipeline needed an agile R&D partner to provide wet-lab capabilities and scientific expertise. Without in-house labs, they relied on Bioneer for flexible, on-demand development support across multiple programs.

Case

Urgent Troubleshooting

A small biotech struggled with product instability during manufacturing at a large CMO, which couldn't establish a suitable buffer exchange for lyophilization. Bioneer quickly developed and implemented a TFF process, enabling successful stabilization, lyophilization, and fill-finish.

De-risk your process early

 Send us a quick message and we´ll check if BioStart fits your needs

*Please notice we have limited slots open for this new service package.

For further information
please contact:

Ryan Jeffrey Polito

Business Development Manager